The Food and Drug Administration (FDA) has issued warning letters to seven companies for selling cannabidiol (CBD) products that violate the Federal Food, Drug, and Cosmetic Act. The companies were given 15 working days to respond with details of how they plan to correct the violations.
CBD products have become increasingly popular in recent years, with many people using them for various purposes such as anxiety, pain, and insomnia. However, the FDA has not yet approved any CBD products, except for one prescription drug for the treatment of seizures associated with two rare forms of epilepsy.
The FDA has been actively monitoring the CBD market and has sent warning letters to companies that make false or misleading claims about their products. The recent warning letters focus on violations such as making unsubstantiated claims about the therapeutic benefits of CBD, marketing CBD products as dietary supplements, and adding CBD to food products.
Companies Violating the Federal Food, Drug, and Cosmetic Act
The seven companies that received warning letters from the FDA are Koi CBD LLC, Pink Collections Inc., Noli Oil, Natural Native LLC, Whole Leaf Organics LLC, Infinite Product Company LLLP, and Apex Hemp Oil LLC. These companies were found to be in violation of the Federal Food, Drug, and Cosmetic Act, which prohibits the sale of any drug or product that has not been approved by the FDA.
False Or Misleading Claims About CBD Products
The FDA has expressed concern about companies that make false or misleading claims about the therapeutic benefits of CBD products. Many companies claim that their CBD products can treat a wide range of conditions, including cancer, Alzheimer’s disease, and Parkinson’s disease. However, these claims are not backed up by scientific evidence, and the FDA has warned that such claims can be dangerous and misleading to consumers.
CBD Products Marketed As Dietary Supplements
The FDA has also warned companies about marketing CBD products as dietary supplements. This is not allowed under current regulations, as CBD has been approved as an active ingredient in a prescription drug. Any product containing CBD that is marketed as a dietary supplement is considered to be in violation of the Federal Food, Drug, and Cosmetic Act.
Adding CBD To Food Products
The FDA has also expressed concern about the addition of CBD to food products. The agency has not yet approved the use of CBD as a food additive, and any product that contains CBD and is marketed as food is considered to be in violation of the Federal Food, Drug, and Cosmetic Act.